Browse

Neurodegenerative diseases such as Alzheimer's and Parkinson's affect an increasing number of people. Their etiology is related to the formation of fibrils and protein aggregates. Therefore, new therapeutic strategies and compounds are required to prevent aggregation of ?-amyloid (A?) peptides. There are some neuropeptides that play an important role in the immune regulation, as well as in neuroprotection; therefore, they might be possible candidates for future drug development. Consequently, our experiments were ...